National Comprehensive Cancer Network joins with Vietnam National Cancer Hospital to enhance cancer treatment
Meeting Announcement
Updates every hour. Last Updated: 26-Apr-2025 12:08 ET (26-Apr-2025 16:08 GMT/UTC)
As critical responders, macrophages can perceive helpful biotechnology as threats. If not created with the right materials or mechanical forces, these devices can trigger an immune response that can cause inflammation, scar tissue or device failure.In an article published in Trends in Biotechnology, researchers highlights= the need to understand macrophage cell behavior to potentially open doors for new or improved biotechnology and targeted immunotherapy treatments.
Researchers at the Centre for Genomic Regulation (CRG) in Barcelona have created the first blueprint of the human spliceosome, the most complex and intricate molecular machine in human biology. The vast majority of human genes – more than nine in ten – are edited by the spliceosome. The sheer number of componentes involved has meant the scientific feat, published today in Science, took more than a decade to complete. The research reveals many new drug targets that could benefit a wide spectrum of diseases including most types of cancer, neurodegenerative conditions and genetic disorders.
Stents to treat various blockages in the human body can themselves become blocked, but a new sensor developed at the University of Michigan for stents that are used in the bile duct may one day help doctors detect and treat stent blockages early, helping keep patients healthier.